Editorial: Immune response to gram-negative bacteria in the lungs
Agnes Jara-Collao,M Cecilia Poli,William Bain,Hernán F. Peñaloza
DOI: https://doi.org/10.3389/fcimb.2024.1503892
IF: 6.073
2024-10-25
Frontiers in Cellular and Infection Microbiology
Abstract:Infectious diseases are a major cause of mortality and morbidity. The most common microbial pathogens accounted for nearly 1 in 7 of all deaths worldwide in 2019 (Collaborators, 2022). Although many infections can cause disease, a small handful of bacteria species account for nearly one-third of all infection-related deaths. In 2019, the 5 most common bacterial species accounted for 7% of global death (Collaborators, 2022), three of which were Gram-negative bacteria. Although infection by Gram-negative bacteria can be fatal at many sites, infections of the lower respiratory tract are a particularly challenging global health burden. In response to this global health challenge, we provide a collection of manuscripts that provide new and key research findings in the study of Gram-negative bacterial infections of the lung and the immune response elicited.Pneumonia, a severe form of lower respiratory tract infection, is characterized by a disruption of gas exchange at the alveoli. Pneumonia is often classified as community acquired pneumonia (CAP) or hospital acquired pneumonia (HAP) according to where it is contracted (Torres et al., 2021). Differences between CAP and HAP are not restricted to where the disease is acquired, but also in terms of etiology and patient risk factors. CAP is commonly caused by respiratory viruses (e.g. rhinovirus, respiratory syncytial virus, influenza, and coronoviridae) and bacteria (Streptococcus pneumoniae) (Jain et al., 2015), while HAP are caused mostly by Gram-negative bacteria such as Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii and others (Jones, 2010). Factors that have been associated with increased risk of HAP are primarily associated with medical procedures (e.g. surgeries), hospitalization for acute diseases (acute respiratory distress syndrome), or underlying co-morbidities such as pre-existing lung disease (Torres et al., 2021). Better understanding of the risk factors that render susceptibility to HAP caused by Gram-negative bacteria is extremely important and highlights opportunities to prevent and manage these infections. One such study included in this collection was conducted in 305 patients admitted to the intensive care unit at a large academic medical center in China. The authors evaluated risk factors associated with mortality during Gram-negative pneumonia, finding that lactic acid levels in circulation, tracheal intubation, and acute kidney injury were all independently associated with increased 30-day mortality during Gram-negative pneumonia (https://www.frontiersin.org/journals/cellular-and-infectionmicrobiology/articles/10.3389/fcimb.2024.1382755/full). Further studies are needed to validate these and other risk factors across different cohorts, as well as to determine whether any HAP risk factor may be treatable to improve patient outcomes.In addition to the current global health burden of Gram-negative bacteria infections, there is a developing health crisis with the rise of elevated antimicrobial resistance (Torres et al., 2021) due to the lack of effective therapies and the high mortality associated with these infections. Epidemiological and genetic studies related to the acquisition of antimicrobial resistance by pathogenic bacteria are a highly dynamic field with importance to patient outcomes. For example, studying the acquisition of genes that confer resistance to last resort antibiotics such as colistin and carbapenems may help to prevent patient mortality, particularly in immunesuppressed patients (Zhang et al., 2022) To develop novel therapies, it may be beneficial to study the host immune response to bacteria. For example, when a pathogenic bacterium reaches the alveolar space, epithelial cells and resident alveolar macrophages rapidly detect the presence of the pathogen through pattern recognition receptors (Nieto et al., 2013;Gonzalez-Ferrer et al., 2021). In conjunction, they initiate a coordinated response that involves the production of antimicrobial peptides, pro-inflammatory cytokines and chemokines required for the recruitment of neutrophils, monocytes and other immune cells relevant for host defense (Nieto et al., 2013;Penaloza et al., 2019;Gonzalez-Ferrer et al., 2021;Penaloza et al., 2021;van der Geest et al., 2023). The close interaction between alveolar macrophages and epithelial cells coordinates the subsequent responses in the lungs against bacteria. This interaction is summarized in a mini- response is optimized against intracellular pathogens such as viruses, the Th2 response is efficient against parasites and the Th17 response is designed to respond against extracellular bacteria such as Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii. Pathogenic bacteria have adapted to different components of the host immune system, which often result either in the disruption and evasion of the host immune response, or in cell death, tissue i -Abstract Truncated-
immunology,microbiology